Stocks & ETFs

I hope everyone had a wonderful holiday and has a very happy and successful New Year. I spent time with my family and of course...

Emerging market stocks appear to be in trouble as investors look to the new year and try to unveil potential themes for 2025. Underscoring the...

The Transportation Sector ETF (IYT) has been reeling for the past 4 weeks. And this decline has wiped out most of 2024's gains. That said, IYT...

We still believe there is a bullish opportunity nearby for treasury bonds, although the support areas we identified in our September post failed to hold. The...

The stock market has been charging higher into year end. Then came the FED interest rate decision and comments. But a even a couple weeks...

In today’s video, we explore potential scenarios for the Nasdaq 100 ETF (NASDAQ:QQQ) through January 2025. While seasonal strength often boosts year-end performance, results...

While the NASDAQ 100 (NASDAQ:QQQ) and many of the Magnificent 7 stocks went on to make new highs, the S&P 500 Equal Weight ETF...

International equities have posted some excellent returns in 2024. But with such U.S. dominance, do many people know? The allocation decision for many investors to...

AbbVie Inc is a global biopharmaceutical company that specializes in the discovery, development, manufacturing, and marketing of advanced medicines. AbbVie focuses primarily on immunology, oncology, neuroscience, and virology treatments, and...

It's been a stellar year for gold and silver and the precious metals sector. After breaking out over $2200, gold surged to $2800+ and was/is...